sulfamerazine has been researched along with Diabetes Mellitus, Type 2 in 2 studies
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Markowicz-Piasecka, M | 2 |
| Huttunen, KM | 2 |
| Mateusiak, Ł | 1 |
| Mikiciuk-Olasik, E | 1 |
| Sikora, J | 2 |
| Broncel, M | 1 |
2 other studies available for sulfamerazine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Sulfenamide and sulfonamide derivatives of metformin can exert anticoagulant and profibrinolytic properties.
Topics: Anticoagulants; Antithrombin III; Blood Coagulation; Diabetes Mellitus, Type 2; Factor X; Fibrinolys | 2018 |
Sulfenamide and Sulfonamide Derivatives of Metformin - A New Option to Improve Endothelial Function and Plasma Haemostasis.
Topics: Diabetes Mellitus, Type 2; Human Umbilical Vein Endothelial Cells; Humans; Metformin; Myocytes, Smoo | 2019 |